nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—THRB—forebrain—attention deficit hyperactivity disorder	0.0375	0.0382	CbGeAlD
Levothyroxine—THRA—forebrain—attention deficit hyperactivity disorder	0.0375	0.0382	CbGeAlD
Levothyroxine—SLC16A2—forebrain—attention deficit hyperactivity disorder	0.034	0.0346	CbGeAlD
Levothyroxine—SERPINA7—nervous system—attention deficit hyperactivity disorder	0.033	0.0336	CbGeAlD
Levothyroxine—SERPINA7—central nervous system—attention deficit hyperactivity disorder	0.0317	0.0323	CbGeAlD
Levothyroxine—THRA—cardiovascular system—attention deficit hyperactivity disorder	0.0317	0.0323	CbGeAlD
Levothyroxine—SLCO1C1—forebrain—attention deficit hyperactivity disorder	0.0312	0.0318	CbGeAlD
Levothyroxine—SERPINA7—cerebellum—attention deficit hyperactivity disorder	0.031	0.0316	CbGeAlD
Levothyroxine—TTR—forebrain—attention deficit hyperactivity disorder	0.0279	0.0284	CbGeAlD
Levothyroxine—SLCO4A1—forebrain—attention deficit hyperactivity disorder	0.025	0.0254	CbGeAlD
Levothyroxine—SLC7A5—cardiovascular system—attention deficit hyperactivity disorder	0.0242	0.0246	CbGeAlD
Levothyroxine—TTR—cardiovascular system—attention deficit hyperactivity disorder	0.0236	0.024	CbGeAlD
Levothyroxine—SLCO1C1—midbrain—attention deficit hyperactivity disorder	0.0206	0.021	CbGeAlD
Levothyroxine—THRB—nervous system—attention deficit hyperactivity disorder	0.0204	0.0207	CbGeAlD
Levothyroxine—THRA—nervous system—attention deficit hyperactivity disorder	0.0204	0.0207	CbGeAlD
Levothyroxine—THRB—central nervous system—attention deficit hyperactivity disorder	0.0196	0.02	CbGeAlD
Levothyroxine—THRA—central nervous system—attention deficit hyperactivity disorder	0.0196	0.02	CbGeAlD
Levothyroxine—THRB—cerebellum—attention deficit hyperactivity disorder	0.0192	0.0195	CbGeAlD
Levothyroxine—THRA—cerebellum—attention deficit hyperactivity disorder	0.0192	0.0195	CbGeAlD
Levothyroxine—SLC7A5—midbrain—attention deficit hyperactivity disorder	0.0189	0.0192	CbGeAlD
Levothyroxine—SLC16A2—nervous system—attention deficit hyperactivity disorder	0.0184	0.0188	CbGeAlD
Levothyroxine—TTR—midbrain—attention deficit hyperactivity disorder	0.0184	0.0187	CbGeAlD
Levothyroxine—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.0179	0.0182	CbGeAlD
Levothyroxine—SLC16A2—central nervous system—attention deficit hyperactivity disorder	0.0178	0.0181	CbGeAlD
Levothyroxine—SLC16A2—cerebellum—attention deficit hyperactivity disorder	0.0174	0.0177	CbGeAlD
Levothyroxine—SLCO1C1—nervous system—attention deficit hyperactivity disorder	0.0169	0.0172	CbGeAlD
Levothyroxine—SLCO4A1—midbrain—attention deficit hyperactivity disorder	0.0165	0.0168	CbGeAlD
Levothyroxine—SLCO1C1—central nervous system—attention deficit hyperactivity disorder	0.0163	0.0166	CbGeAlD
Levothyroxine—THRB—brain—attention deficit hyperactivity disorder	0.0156	0.0158	CbGeAlD
Levothyroxine—THRA—brain—attention deficit hyperactivity disorder	0.0156	0.0158	CbGeAlD
Levothyroxine—SLC7A5—nervous system—attention deficit hyperactivity disorder	0.0155	0.0158	CbGeAlD
Levothyroxine—TTR—nervous system—attention deficit hyperactivity disorder	0.0151	0.0154	CbGeAlD
Levothyroxine—SLC7A5—central nervous system—attention deficit hyperactivity disorder	0.015	0.0152	CbGeAlD
Levothyroxine—SLC7A5—cerebellum—attention deficit hyperactivity disorder	0.0146	0.0149	CbGeAlD
Levothyroxine—TTR—central nervous system—attention deficit hyperactivity disorder	0.0146	0.0148	CbGeAlD
Levothyroxine—TTR—cerebellum—attention deficit hyperactivity disorder	0.0142	0.0145	CbGeAlD
Levothyroxine—SLC16A2—brain—attention deficit hyperactivity disorder	0.0141	0.0144	CbGeAlD
Levothyroxine—SLCO4A1—nervous system—attention deficit hyperactivity disorder	0.0136	0.0138	CbGeAlD
Levothyroxine—SLCO4A1—central nervous system—attention deficit hyperactivity disorder	0.0131	0.0133	CbGeAlD
Levothyroxine—SLCO1C1—brain—attention deficit hyperactivity disorder	0.0129	0.0132	CbGeAlD
Levothyroxine—SLCO4A1—cerebellum—attention deficit hyperactivity disorder	0.0128	0.013	CbGeAlD
Levothyroxine—SLC7A5—brain—attention deficit hyperactivity disorder	0.0119	0.0121	CbGeAlD
Levothyroxine—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.0118	0.012	CbGeAlD
Levothyroxine—TTR—brain—attention deficit hyperactivity disorder	0.0116	0.0118	CbGeAlD
Levothyroxine—SLCO4A1—brain—attention deficit hyperactivity disorder	0.0104	0.0106	CbGeAlD
Levothyroxine—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00972	0.00989	CbGeAlD
Levothyroxine—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00935	0.00952	CbGeAlD
Levothyroxine—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00914	0.00931	CbGeAlD
Levothyroxine—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00743	0.00756	CbGeAlD
Levothyroxine—ALB—brain—attention deficit hyperactivity disorder	0.00738	0.00752	CbGeAlD
Levothyroxine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.006	0.0061	CbGeAlD
Levothyroxine—CYP2C8—brain—attention deficit hyperactivity disorder	0.00519	0.00528	CbGeAlD
Levothyroxine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00507	0.00516	CbGeAlD
Levothyroxine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.0046	0.00468	CbGeAlD
Levothyroxine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00443	0.00451	CbGeAlD
Levothyroxine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00396	0.00403	CbGeAlD
Levothyroxine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00325	0.00331	CbGeAlD
Levothyroxine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00313	0.00319	CbGeAlD
Levothyroxine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00306	0.00312	CbGeAlD
Levothyroxine—ABCB1—brain—attention deficit hyperactivity disorder	0.00249	0.00253	CbGeAlD
Levothyroxine—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.00141	0.0788	CbGpPWpGaD
Levothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000691	0.0385	CbGpPWpGaD
Levothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000691	0.0385	CbGpPWpGaD
Levothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000632	0.0352	CbGpPWpGaD
Levothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000579	0.0323	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000546	0.0305	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00047	0.0262	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000437	0.0243	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000437	0.0243	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.000397	0.0221	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000351	0.0196	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000351	0.0196	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000335	0.0187	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000335	0.0187	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000329	0.0183	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000328	0.0183	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000321	0.0179	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000321	0.0179	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000317	0.0177	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000307	0.0171	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000294	0.0164	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000281	0.0156	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000268	0.0149	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000263	0.0146	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000258	0.0144	CbGpPWpGaD
Levothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000241	0.0134	CbGpPWpGaD
Levothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000241	0.0134	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00022	0.0123	CbGpPWpGaD
Levothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00022	0.0123	CbGpPWpGaD
Levothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000202	0.0112	CbGpPWpGaD
Levothyroxine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00017	0.00949	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000167	0.00929	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000159	0.00886	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000142	0.00792	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.000142	0.00792	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000142	0.00791	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.00769	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000131	0.0073	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000126	0.00702	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000125	0.00696	CbGpPWpGaD
Levothyroxine—TTR—Disease—STUB1—attention deficit hyperactivity disorder	0.000124	0.00691	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000122	0.00681	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000122	0.00681	CbGpPWpGaD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000114	0.00636	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000112	0.00624	CbGpPWpGaD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000112	0.00623	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000111	0.0062	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000107	0.00595	CbGpPWpGaD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000102	0.00571	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.000101	0.00565	CbGpPWpGaD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.75e-05	0.00543	CbGpPWpGaD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	8.97e-05	0.005	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.68e-05	0.00484	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	7.67e-05	0.00427	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.46e-05	0.00416	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.31e-05	0.00407	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.17e-05	0.00399	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	6.4e-05	0.00357	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	6.11e-05	0.0034	CbGpPWpGaD
Levothyroxine—TTR—Disease—SNAP25—attention deficit hyperactivity disorder	5.88e-05	0.00328	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.8e-05	0.00323	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	5.61e-05	0.00312	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.52e-05	0.00308	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	5.35e-05	0.00298	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	5.33e-05	0.00297	CbGpPWpGaD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	5.23e-05	0.00292	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	5.23e-05	0.00291	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.22e-05	0.00291	CbGpPWpGaD
Levothyroxine—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.18e-05	0.00289	CbGpPWpGaD
Levothyroxine—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.14e-05	0.00287	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.07e-05	0.00282	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—EP300—attention deficit hyperactivity disorder	4.71e-05	0.00262	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.56e-05	0.00254	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.43e-05	0.00247	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	4.38e-05	0.00244	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.34e-05	0.00242	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	4.19e-05	0.00234	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.12e-05	0.00229	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	4e-05	0.00223	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.99e-05	0.00222	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.92e-05	0.00218	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.9e-05	0.00217	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.87e-05	0.00216	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TPH2—attention deficit hyperactivity disorder	3.81e-05	0.00212	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.81e-05	0.00212	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—DPYD—attention deficit hyperactivity disorder	3.75e-05	0.00209	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.71e-05	0.00207	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.61e-05	0.00201	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.49e-05	0.00194	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.05e-05	0.0017	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	3e-05	0.00167	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3e-05	0.00167	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.95e-05	0.00164	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.9e-05	0.00162	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.8e-05	0.00156	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.78e-05	0.00155	CbGpPWpGaD
Levothyroxine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.76e-05	0.00154	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	2.75e-05	0.00153	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.74e-05	0.00153	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.56e-05	0.00143	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.56e-05	0.00143	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.53e-05	0.00141	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.52e-05	0.0014	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.4e-05	0.00133	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.34e-05	0.00131	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—COMT—attention deficit hyperactivity disorder	2.31e-05	0.00129	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—MAOA—attention deficit hyperactivity disorder	2.29e-05	0.00128	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.28e-05	0.00127	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.23e-05	0.00124	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.22e-05	0.00124	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.13e-05	0.00119	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.12e-05	0.00118	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.05e-05	0.00114	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.95e-05	0.00109	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.95e-05	0.00109	CbGpPWpGaD
Levothyroxine—TTR—Disease—EP300—attention deficit hyperactivity disorder	1.91e-05	0.00106	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.86e-05	0.00104	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.82e-05	0.00101	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.8e-05	0.001	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	1.79e-05	0.000999	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.75e-05	0.000974	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	1.55e-05	0.000865	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.54e-05	0.000859	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.49e-05	0.000833	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	1.47e-05	0.00082	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.47e-05	0.00082	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	1.46e-05	0.000816	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.46e-05	0.000816	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	1.45e-05	0.000807	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	1.44e-05	0.000803	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.35e-05	0.00075	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.34e-05	0.000746	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.34e-05	0.000746	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.28e-05	0.000715	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.28e-05	0.000715	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.26e-05	0.000703	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.18e-05	0.000656	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.17e-05	0.000654	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	0.000652	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.14e-05	0.000638	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	0.000624	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	0.000621	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.03e-05	0.000571	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—attention deficit hyperactivity disorder	9.91e-06	0.000552	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.76e-06	0.000544	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	9.38e-06	0.000523	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	8.92e-06	0.000497	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	8.87e-06	0.000494	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	8.86e-06	0.000494	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	8.81e-06	0.000491	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.59e-06	0.000479	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.54e-06	0.000476	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.9e-06	0.00044	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.9e-06	0.00044	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.78e-06	0.000434	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.77e-06	0.000433	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	7.77e-06	0.000433	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.72e-06	0.00043	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.23e-06	0.000403	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	6.66e-06	0.000371	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.32e-06	0.000352	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.01e-06	0.000335	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.79e-06	0.000267	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.75e-06	0.000265	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	3.83e-06	0.000213	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	3.8e-06	0.000212	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.33e-06	0.000186	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.05e-06	0.000114	CbGpPWpGaD
